Amphastar Pharmaceuticals, Inc. Annual Cost of Revenue in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from 2012 to 2023.
  • Amphastar Pharmaceuticals, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $87.2M, a 19.5% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $323M, a 22.1% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2023 was $293M, a 17.3% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2022 was $250M, a 5.08% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Cost of Revenue for 2021 was $238M, a 15.3% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $293M +$43.1M +17.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $250M +$12.1M +5.08% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $238M +$31.5M +15.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $207M +$16.1M +8.44% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $190M +$2.75M +1.47% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $188M +$38M +25.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $150M -$1.3M -0.86% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $151M -$23.2M -13.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $174M +$15M +9.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $159M +$16.5M +11.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $143M +$28.7M +25.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $114M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.